- Home
- CPD Activities
- Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome
Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome
Name | World Continuing Education Alliance |
Activity Title | Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome |
Details | Irritable bowel syndrome (IBS) is a common gut disorder that affects approximately 11% of the global population.. The Rome working team recommended classifying subjects with IBS into different sub-groups depending on their bowel habits changes predominance. The IBS sub-groups included IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), Mixed IBS (IBS-M), and Un-subtyped IBS.. To understand the pathogenesis of irritable bowel syndrome (IBS), previous studies have developed a rat model utilizing infection with. Furthermore, the development of antibodies to CdtB was associated with altering gut microbiota associated with reducing specific interstitial cells of Cajal (ICC).. The present study aims to detect and quantify anti-CdtB and anti-vinculin levels in subjects with IBS and their possible role in diagnosing different IBS subtypes. |
Competence | Public Health |
Start Date | <span class="not-set">(not set)</span> |
End Date | <span class="not-set">(not set)</span> |
Event Time | 09:15 PM |
Location | World Continuing Education Alliance eLearning System |
Cost (UGX) | 0 |
CPD Points | 1 |
---|